Zobrazeno 1 - 10
of 83
pro vyhledávání: '"P. L. Oe"'
Peritoneal Kinetics and Mesothelial Markers in CCPD Using Icodextrin for Daytime Dwell for Two Years
Autor:
W. Van Dorp, N. Posthuma, H. A. T. Dekker, E.M. Peers, H. A. Verbrugh, P. L. Oe, P. M. Ter Wee, A. J. M. Donker
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 20:174-180
Objective To evaluate the safety, efficacy, and biocompatibility of icodextrin (Ico), continuous cycling peritoneal dialysis (CCPD) patients were treated for 2 years with either Ico- or glucose (Glu)-containing dialysis fluid for their daytime dwell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ded3826699cfa68fc06eb21dcac198f4
https://doi.org/10.1177/089686080002000203
https://doi.org/10.1177/089686080002000203
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 19:334-342
Objective To investigate peritoneal defense during icodextrin use in continuous cyclic peritoneal dialysis (CCPD). Design In an open, prospective, 2-year follow-up study, CCPD patients were randomized to either glucose (Glu) or icodextrin (Ico) for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3fdd07d4a5b7b09e5e9d9110943e1d2
https://doi.org/10.1177/089686089901900409
https://doi.org/10.1177/089686089901900409
Publikováno v:
Nephrology Dialysis Transplantation, 13, 2341-2344. Oxford University Press
Background and methods. In a randomized study or the biocompatibility of icodextrin (I) versus glucose (G) in CCPD we used icodextrin or glucose for the long daytime dwell. During the night-time dwells glucose was used in all patients. In case of per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f04c783256e93fb54e5d32f04b2bad
https://hdl.handle.net/1765/67741
https://hdl.handle.net/1765/67741
Autor:
H. A. Verbrugh, N. Posthuma, E.M. Peers, Ab J.M. Donker, P. M. Ter Wee, P. L. Oe, W. Van Dorp
Publikováno v:
Peritoneal Dialysis International, 17, 602-607. Multimed Inc.
ObjectiveTo evaluate the safety, efficacy, and biocompatibility of icodextrin and glucose-containing dialysis fluid during continuous cycling peritoneal dialysis (CCPD), patients were treated for 2 years with either icodextrin or glucose-containing d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604c03361401eb253734f8a39f980b5f
https://doi.org/10.1177/089686089701700613
https://doi.org/10.1177/089686089701700613
Autor:
C. W. H. De Fijter, W. M. de Fijter, B. Oe, P. M. J. M. De Vries, B. Straver, P. L. Oe, P. Stevens
Publikováno v:
The International Journal of Artificial Organs. 20:371-374
The purpose of the present study was to investigate whether total body bioelectrical impedance analysis (BIA) could be appropriate to assess normohydration (i.e. dry weight) in hemodialysis patients. This study is warranted, because the simultaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a25bad1084841fd8d827cb3d88adcc0
https://doi.org/10.1177/039139889702000703
https://doi.org/10.1177/039139889702000703
Publikováno v:
Nephron. 74:26-32
The biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid (AA-PDF) was compared to that of a 2.27% glucose-based peritoneal dialysis fluid (G-PDF). Peritoneal macrophages (PMO), isolated from the peritoneal dialysis (PD) effluent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4f0000cf13e3097f51a69bdb88feac
https://doi.org/10.1159/000189277
https://doi.org/10.1159/000189277
Autor:
W. M. de Fijter, P. M. Kouw, A. J. M. Donker, P. L. Oe, C. W. H. De Fijter, Harald F. H. Brulez, P. M. J. M. De Vries
Publikováno v:
Nephrology Dialysis Transplantation. 9:574-584
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f5cf5114faf5b77f225b2d0046b16b2
https://doi.org/10.1093/ndt/9.5.574
https://doi.org/10.1093/ndt/9.5.574
Autor:
Kenji Sawanishi, A.A. Bouman, P. L. Oe, Shigetake Sasayama, Kim M. Blindauer, J. van der Meulen, Andrew L. Zydney, John K. Leypoldt, P.C. Huijgens, Masatomo Yashiro, Leah J. Langsdorf, Munehiro Matsushima, Ryoichi Nagura, Eri Muso, M.J.F.M. Janssen
Publikováno v:
Blood Purification. 12:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a36aaa6f9a5d8acfb4bac15366fee0
https://doi.org/10.1159/000170176
https://doi.org/10.1159/000170176
Publikováno v:
Blood Purification. 12:308-316
Anticoagulation with citrate in combination with a calcium-free, magnesium-containing dialysate (Ca-Mg+) and intravenous supplementation of calcium is a safe procedure in renal failure patients at high risk of bleeding. Since magnesium may antagonize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7547b71e70a1423eceb51dc7b11037a6
https://doi.org/10.1159/000170179
https://doi.org/10.1159/000170179